Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2536562123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Valentina Varela und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Neurodegeneración, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Nerve Growth Factor, Nerve Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Universidad de la República Uruguay (UdelaR), UdelaR | Comisión Sectorial de Investigación Científica (CSIC).
Abstract (Originalsprache)
Nerve growth factor (NGF) is a member of the neurotrophin family, essential for neuronal survival and phenotypic maintenance. However, in vitro, its function can be disrupted by oxidative posttranslational modifications such as tyrosine nitration. Nitrated NGF (NO 2 NGF) has been shown to have a gain-of-toxic, pro-apoptotic, activity in motoneuron cultures. Herein, we report the generation and characterization of monoclonal antibodies (mAbs) that specifically recognize NO 2 NGF to unravel its formation in vivo. Using hybridoma technology, we produced mAbs with high affinity and selectivity for NO 2 NGF, as demonstrated immunochemically and by surface plasmon resonance. The antibodies elicit neutralizing capacity to NO 2 NGF in neuronal cells. Nitrated Tyr52 within the NGF 48–58 sequence was identified as the primary antigenic determinant by crystallographic analysis of antibody:peptide complexes at atomic resolution, peptide-based epitope mapping and molecular dynamics simulations, whereas local sequence NGF motifs around the nitrated tyrosine are important for protein specificity. The antibodies revealed NO 2 NGF accumulation in amyotrophic lateral sclerosis (ALS) rodent models and human subjects. Indeed, immunofluorescence showed selective accumulation of NO 2 NGF in spinal cord regions undergoing motor neuron degeneration, as well as in sciatic nerves and neuromuscular junctions. Our findings establish NGF nitration as an oxidative hallmark in ALS and demonstrate that monoclonal antibodies targeting this chemical modification are powerful tools for both mechanistic studies and biomarkers development. This work proposes a link between neurotrophin nitration and neurodegenerative disease progression and opens avenues for therapeutic exploration along the peroxynitrite-tyrosine nitration pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Neurodegeneración, Institut Pasteur de Montevideo, Montevideo 11400, Uruguay.
- Departamento de Bioquímica, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.
- Centro de Investigaciones Biomédicas (CEINBIO), Facultad de Medicina, Universidad de la Republica, Montevideo 11800, Uruguay.
- Departamento de Neurobiología Celular y Molecular, Instituto de Investigaciones Biológicas Clemente Estable Montevideo, Montevideo 11600, Uruguay.
- Programa de Alimentos y Salud Humana (PAyS), Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.
- Departamento de Histología y Embriología, Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.
ORCID-Profile: Santiago Garcimartín, Ari Zeida, Mariano Martinez, Pedro M Alzari, Rafael Radi
Förderung
- Universidad de la República Uruguay (UdelaR)
- UdelaR | Comisión Sectorial de Investigación Científica (CSIC)
Zitieren
APA
Varela, V., Garcimartín, S., Trias, E., Zeida, A., Richter, M., de León, A., Miquel, E., King, P. H., Vulliez-Le Normand, B., Martinez, M., Alzari, P. M., Bartesaghi, S., Radi, R., & Barbeito, L. (2026). Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2536562123
Vancouver
Varela V, Garcimartín S, Trias E, Zeida A, Richter M, de León A, et al. Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2536562123
BibTeX
@article{Varela2026,
author = {Varela, Valentina and Garcimartín, Santiago and Trias, Emiliano and Zeida, Ari and Richter, Monique and de León, Andrés and Miquel, Ernesto and King, Peter H and Vulliez-Le Normand, Brigitte and Martinez, Mariano and Alzari, Pedro M and Bartesaghi, Silvina and Radi, Rafael and Barbeito, Luis},
title = {Monoclonal antibodies against nitrated nerve growth factor reveal an oxidation-dependent pathogenic hallmark in ALS},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2536562123}
}
EUVIMED